Develop

Novel Approach to Delivering Drugs Across the Blood-Brain Barrier to Treat Brain Tumors

Understanding cat locomotion could help develop a better treatment for human spinal cord injury

Cats always land on their feet, but what makes them so agile? Their unique sense of balance has more in common with humans than meets the eye. Georgia Institute of Technology researchers are studying cat locomotion to better understand how the spinal cord works to help humans with partial spinal cord injuries walk and maintain …

Understanding cat locomotion could help develop a better treatment for human spinal cord injury Read More »

ajc-burgerMenu-background

Breaking: Wellstar and Augusta University Health develop partnership plan

Augusta University’s health care system is part of Augusta University and is ultimately under the control of the Board of Trustees, which oversees Georgia’s university system. The Board of Regents said in a statement it was exploring a partnership to provide “more opportunities for students at the state’s only public medical school to learn and …

Breaking: Wellstar and Augusta University Health develop partnership plan Read More »

Learn how to develop an effective crisis plan for difficult times

Learn how to develop an effective crisis plan for difficult times

Thinking about the “worst-case scenario” isn’t usually a pleasant activity, but it might give you the reassurance you need to proceed with confidence. Planning for a mental health crisis can seem daunting, and it’s important not to get stuck in a negative spiral. But gentle preparation can be reassuring, helping us think about what we …

Learn how to develop an effective crisis plan for difficult times Read More »

a man in a white coat smiling

Bacteria on the International Space Station develop drug resistance

Acinetobacter pittii (A. pittii), a type of bacteria, is evolving to become more resistant to antibiotics and is finding ways to survive in the harsh environment of the International Space Station, according to new research from scientists at Weill Cornell Medicine. “The study of bacteria found on the space station and their resistance to antimicrobial …

Bacteria on the International Space Station develop drug resistance Read More »

TopGum signs a 5-year agreement to develop gummy supplements for a major international company

TopGum signs a 5-year agreement to develop gummy supplements for a major international company

TopGum Industries, an Israeli maker of dietary supplements and gum candies, announced on Sunday that it has signed a five-year deal to develop nutritional supplements for a major multinational. TopGum described the unnamed entity as a “large international company worth more than $150 billion that produces and markets its products in approximately 200 countries around …

TopGum signs a 5-year agreement to develop gummy supplements for a major international company Read More »

nj’s Logo

Struggling During COVID, I Helped My School Develop a Mental Health Course | Opinion

To note: This story was originally posted by chalk beat. By Dashawn Sheffield I went to 19 funerals in the first year of COVID. When I wasn’t saying goodbye to the people I loved, I was in front of a screen that was my connection to school and my friends for a year and a …

Struggling During COVID, I Helped My School Develop a Mental Health Course | Opinion Read More »

Yale researchers develop first FDA-approved drug to delay autoimmune diseases

Yale researchers develop first FDA-approved drug to delay autoimmune diseases

Kevan Herold of Yale School of Medicine led clinical trials of teplizumab, a drug that delays the development of type 1 diabetes, which affects about 1.95 million Americans. Chloe Nield and James Steele 11:59 p.m., November 30, 2022 Staff Journalist and Contributing Journalist Eric Wang, Senior Photographer Teplizumab, a drug that delays type 1 diabetes, …

Yale researchers develop first FDA-approved drug to delay autoimmune diseases Read More »

Dr. Samuel Katz: Innovative Scientist Who Helped Develop the Measles Vaccine - Aish.com Movers & Shakers, Featured, History

Dr. Samuel Katz: Innovative Scientist Who Helped Develop the Measles Vaccine – Aish.com Movers & Shakers, Featured, History

Dr. Samuel Katz, the renowned virologist who was part of the research team that developed the measles vaccine, died recently at the age of 95. His pioneering work has saved countless children’s lives. Born in New Hampshire to Morris and Ethel Katz, Samuel went to Dartmouth College in 1944, when he was 17. His first …

Dr. Samuel Katz: Innovative Scientist Who Helped Develop the Measles Vaccine – Aish.com Movers & Shakers, Featured, History Read More »

RVAC MEDICINES AND A*STAR TO DEVELOP mRNA PRODUCTION CAPACITIES IN SINGAPORE

RVAC MEDICINES AND A*STAR TO DEVELOP mRNA PRODUCTION CAPACITIES IN SINGAPORE

SINGAPORE, November 20, 2022 /PRNewswire/ — RVAC Medicines Pte. (RVAC), a messenger RNA (mRNA) technology platform company incubated by CBC Group, a dedicated healthcare asset management company headquartered in Singaporeand the Agency for Science, Technology and Research (A*STAR) today announced the signing of a Master Research Collaboration Agreement to jointly investigate and develop solutions to …

RVAC MEDICINES AND A*STAR TO DEVELOP mRNA PRODUCTION CAPACITIES IN SINGAPORE Read More »